Sodium Picosulfate
Sodium picosulfate is a stimulant laxative used for the treatment of constipation and bowel cleansing before diagnostic procedures such as colonoscopy. It acts by stimulating the nerve endings in the colonic mucosa, increasing intestinal peristalsis and promoting bowel movements. It is activated by intestinal bacteria in the colon, producing metabolites that stimulate colonic contractions and reduce water absorption. Sodium picosulfate is available in the form of oral tablets and drops, often in combination with other laxatives. It usually produces a laxative effect within 6–12 hours. Common side effects include abdominal cramps, diarrhoea, nausea and bloating. Excessive or prolonged use may cause dehydration and electrolyte imbalance. It is generally recommended for short-term use under medical supervision.
Sodium Picosulfate was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Sodium Picosulfate, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Sodium Picosulfate from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Sodium Picosulfate, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
